EP2872183
AAV-MEDIATED GENE THERAPY FOR RPGR X-LINKED RETINAL DEGENERATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.1.2013EP published:
26.9.2018EP application number:
13816245.8
EPO information:
European Patent Register
Max expiry date:
22.1.2033
Title:
AAV-MEDIATED GENE THERAPY FOR RPGR X-LINKED RETINAL DEGENERATION
Timeline
Today
23.1.2013EP application
26.9.2018EP Publication
Owner
Name:
The Trustees of The University of PennsylvaniaAddress:
3160 Chestnut Street Suite 200, 19104, Philadelphia, PA, US
Name:
University of Florida Research Foundation, Inc.Address:
223 Grinter Hall, 32611, Gainesville, FL, US
Inventor
Name:
BELTRAN, William, A.Address:
Philadelphia, PA, US
Name:
AGUIRRE, Gustavo, D.Address:
Philadelphia, PA, US
Name:
JACOBSON, Samuel, G.Address:
Penn Valley, PA, US
Name:
CIDECIYAN, Artur, V.Address:
Philadelphia, PA, US
Name:
LEWIN, Alfred, S.Address:
Gainesville, FL, US
Name:
BOYE, Sanford, L.Address:
Gainesville, FL, US
Name:
HAUSWIRTH, William, W.Address:
Gainesville, FL, US
Name:
DENG, Wen-TaoAddress:
Gainesville, FL, US
Priority
Number:
201261670355 PDate:
11.7.2012Country:
US
Classification
Categories:
A61K 48/00, A61K 38/17, A61K 38/46, A61P 27/02, C07K 14/47